Combination of Molex VersaBeam EBO Backplane Connector and Teramount TeraVERSE detachable fiber connector boosts serviceability and slashes deployment time by 85% -- Enhanced CPO toolkit with ...
Nvidia debuts Vera Rubin, a seven-chip AI platform designed to deliver cheaper, faster AI infrastructure with support from OpenAI, Anthropic and Meta.
Space may be the next frontier for the AI infrastructure boom, but it will take some work to make that happen, Nvidia CEO ...
Chipotle is offering guests free chips and queso blanco for a limited time. In honor of National Tortilla Chip Day, held each year on Feb. 24, the popular restaurant chain is giving away the free side ...
Cystic fibrosis (CF) specialist Vertex is tracking two newer launches that speak to its efforts to expand its prowess beyond those roots. Despite mixed early results for those rollouts so far, the ...
Facing soaring memory-chip prices, the world’s biggest electronics companies are staring at a list of unpalatable responses: charging consumers more, eating the costs or rejiggering product specs.
WE EARNED IT, RIGHT? WE CERTAINLY DID. WE STRUGGLED THROUGH IT. ALL RIGHT. THANKS, CHRISTINE. LANCASTER BASED COOKIE CHAIN TAYLOR CHIP. FILED FOR BANKRUPTCY. THE COMPANY SAYS IT’S ALSO CLOSED TWO OF ...
This morning, shares of two of the largest computer memory companies that trade on U.S. markets are up yet again. The stock prices of Micron Technology, Inc. (Nasdaq: MU) and Sandisk Corporation ...
IN THE SEMICONDUCTOR industry, Arm is everywhere and nowhere. Designs from the British-based, American-listed, Japanese-controlled firm sit in almost all the world’s smartphones and most other ...
Vertex has delivered earnings growth over the past decade thanks to its leadership in cystic fibrosis treatment. In recent years, the company has launched products in other treatment areas too. On top ...
Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Journavx and Casgevy sales remain niche, raising doubts about their ability to drive ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results